Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.69
+0.03 (0.39%)
At close: Jan 26, 2026, 4:00 PM EST
7.71
+0.02 (0.26%)
After-hours: Jan 26, 2026, 4:10 PM EST
Fennec Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts that cover Fennec Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $15, which forecasts a 95.06% increase in the stock price over the next year. The lowest target is $13 and the highest is $18.
Price Target: $15 (+95.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Fennec Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $18 | Buy | Initiates | $18 | +134.07% | Jan 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +69.05% | Aug 21, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +82.05% | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +69.05% | May 20, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +69.05% | May 14, 2025 |
Financial Forecast
Revenue This Year
45.96M
from 47.54M
Decreased by -3.33%
Revenue Next Year
78.49M
from 45.96M
Increased by 70.78%
EPS This Year
-0.14
from -0.02
EPS Next Year
0.62
from -0.14
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 49.0M | 91.3M | ||||
| Avg | 46.0M | 78.5M | ||||
| Low | 41.7M | 59.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.1% | 98.7% | ||||
| Avg | -3.3% | 70.8% | ||||
| Low | -12.3% | 29.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.07 | 0.97 | |
| Avg | -0.14 | 0.62 | |
| Low | -0.19 | 0.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.